1. Field Management of Chemical and Biological Casualties Handbook. Garr JH, ed. 2016, Borden Instutute, Office of the Surgeon General, Falls Church, VA.
2. Joint Trauma System, Chemical, Biological, Radiological and Nuclear Injury Response Part I: Initial Response Clinical Practice Guideline, 01 May 2018. https://jts.health.mil/index.cfm/PI_CPGs/cpgs. Accessed Jan 2019.
3. Suzuki T, Morita H, Ono K,.et al. Sarin poisoning in Tokyo subway. The Lancet. 1995;345(8962) 1446 – 1447.
4. Okumura T, Taskasu N, Ishimatsu S, et al. Report on 640 victims of the Tokyo subway sarin attack. Annals of Emergency Medicine. 1996;28(2): 129-35.
5. Baskin SL, Kelly JB, Maliner BL, et al. Cyanide poisoning. In: Medical aspects of chemical and biological warfare. Washington D.C.: Office of the Surgeon General; 2008: 371-410.
6. Parachini JV. The World Trade Center bombers (1993). In: Tucker JB, ed. Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons. Cambridge, MA: MIT Press; 2000: 185-206.
7. Baud FJ, Borron SW, Mégarbane B, et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. 2002 Sep;30(9):2044-50.
8. Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Annals of Emergency Medicine. 2001;37(6): 155-68.
9. Bebarta VS, Tanen DA, Lairet J, et al. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Annals of Emergency Medicine. 2010;55: 345–51.
10. Bebarta VS, Pitotti RL, Dixon P, et al. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest. Annals of Emergency Medicine. 2012;60(4): 415-22.
11. Bebarta VS, Pitotti RL, Boudreau S, et al. Intraosseous versus intravenous infusion of hydroxocobalamin for the treatment of acute severe cyanide toxicity in the swine model. Academic Emergency Medicine. 2014;21:1203-1211.
12. Brouard A, Blaisot B, Bismuth. Hydroxocobalamin in cyanide poisoning. Journal de Toxicologie Clinique et Experimentale. 1987;7(3): 155-68.
13. Hall AH, Rumack BH. Hydroxycobalamin/sodium thiosulfate as a cyanide antidote. Journal of Emergency Medicine. 1987;5(2): 115-21
14. Bebarta VS, Tanen DA, Boudreau S, et al. Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model. Annals of emergency medicine. 2014;64(6): 612-19.
15. Dulaney Jr MD, Brumley M, Willis JT, Hume AS. Protection against cyanide toxicity by oral alpha-ketoglutaric acid. Veterinary and Human Toxicology. 1991;33:571-5.
16. Niknahad H1, Ghelichkhani E. Antagonism of cyanide poisoning by dihydroxyacetone. Toxicol Lett. 2002 Jun 14;132(2):95-100.
17. Hoffman RS, Howland MA, Lewin NA, et al. Toxicologic Emergencies. 10th Ed. New York, NY: McGraw-Hill Education; 2015.
18. Food and Drug Administration. Pyrodistigmine bromide package insert.
19. McDonough JH. Midazolam: An improved anticonvulsant treatment for nerve agent-induced seizures. Paper presented at: ADA409494 Proceedings of the 2001 Edgewood Chemical Biological Center Scientific Conference on Chemical and Biological Defense Research; Mar 2001; Hunt Valley, MD.
20. Sidell FR. Nerve Agents. In Medical Aspects of Chemical and Biological Warfare, Textbook of Military Medicine, Part I Warfare, Weaponry and the Casualty (Sidell FR, Takafuji ET, and Franz DR eds). The Office of the Surgeon General. Washington DC. 1997: 129-179.
21. Sidell FR. Soman and Sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clinical Toxicology. 1974;7(1): 1-17.
22. Shih T, McDonough JH. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacology, biochemistry and behavior. 1999;64:147-153.
23. Taylor P. Anticholinesterase agents (Chapter 10) in The pharmacological basis of therapeutics (6th Ed), Gilman AG, Goodman LS, Rall TW, Murad F. Macmillan, New York.1985: 110-129.
24. Ward JR. Case report: exposure to nerve gas. In: Whittenberger JL, ed. Artificial Respiration: Theory and Application. New York, NY: Harper and Row; 1962: 258-65.
25. Harris LW, Gennings C, Carter WH, et al. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug and Chemical Toxicology. 1994;17(1): 35-50.
26. Koplovitz I, Schulz S. Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning. Military Medicine. 2010;175(11): 878-82.
27. Clement JG. Survivors of soman poisoning: recovery of the soman LD50 to control value in the presence of extensive acetylcholinesterase inhibition. Archives of Toxicology. 1989;63(2): 150-54.
28. Dawson, R. M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994;14: 317–331. doi:10.1002/jat.2550140502
29. Gunnarson M WS, Seidal T, Lennquist S. Effects of inhalation of corticosteroids immediately after experimental chlorine injury. Journal of Trauma and Acute Care Surgery. 2000;48(1): 101.
30. Kassa J. Review of Oximes in the Antidotal Treatment of Poisoning by Organophosphorus Nerve Agents. Journal of Toxicology. 2002;40(6): 803-16.
31. Snider TH, Yeung DT, Jett, DA, Babin M. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig. J Toxicol Sci, Jul 2016. ;41(4):511-21.
32. Wilhelm CM, Snider TH, Babin MC, et al. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides. Toxicology and Applied Pharmacy. 2014;281(3):254-65.
33. Worek F, Aurbek N, Thiermann H. Reactivation of organophosphate-inhibited human AchE by combinations of obidoxime and HI 6 in vitro. Journal of Apllied Toxicology. 2007;27(6):582-588.
34. Hamilton MG, Lundy PM. HI-6 therapy of soman and tabun poisoning in primates and rodents. Archives of Toxicology. 1989;63(2): 144-49.
35. Marrs TC, Maynard RL, Sidell FR. The use of benzodiazepines in organophosphorus nerve agent intoxication. In: Chichester, UK: John Wiley & Sons, Ltd; 2007:331-342
36. Shih TM, Duniho SM, and McDonough JH. Control of Nerve Agent-Induced Seizures is Critical for Neuroprotection and Survival. U.S. Army Medical Research Institute of Chemical Defense Report. Jan 2002. 
37. Diller WF. Early diagnosis of phosgene overexposure. Toxicology and Industrial Health. 1985;1(2): 73-80.
38. Nelson LS, Odujebe OA. Simple Asphyxiants and Pulmonary Irritants. In Goldfrank’s Toxicologic Emergencies 10th ed. McGraw Hill. 2015.
39. Wang J, Zhang L, Walther SM. Administration of aerosolized terbutaline and budesonide reduces chlorine gas-induced acute lung injury. J Trauma. Apr 2004;56(4):850-862.
40. Bosse GM. Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. Journal of Toxicology – Clinical Toxicology. 1994;32:233-241.
41. Vinsel PJ. Treatment of acute chlorine gas inhalation with nebulized sodium bicarbonate. J Emerg Med. 1990 May-Jun 1990;8(3):327-329.
42. Guo YL, Kennedy TP, Michael R, et al. Mechanism of phosgene induced lung injury: role of arachidonate mediators. Journal of Applied Physiology. 1990;69(5): 1615-22
43. Frosolono MF, Scarpelli EM, Holzman BH, et al. Effect of aminophylline, hydrocortisone, and prostaglandin E1 on survival time and percent lung water in rabbits after exposure to phosgene. American Review of Respiratory Disease. 1978;117(suppl): 233-34.
44. Sciuto AM, Strickland PT, Kennedy TP, Gurtner GH. Postexposure treatment with aminophylline protects against phosgene induced acute lung injury. Experimental Lung Research. 1997;23(4): 317-32.
45. Kennedy TP, Michael JR, Hoidal JR, et al. Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene. Journal of Applied Physiology. 1989;67(6): 2542-52.
46. Sciuto AM, Stotts RR, Hurt HH. Efficacy of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury. Journal of Applied Toxicology. 1996;16(5): 381-84.
47. Sciuto AM, Strickland PT, Kennedy TP, Gurtner GH. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. American Journal of Respiratory and Critical Care Medicine. 1995;151(3 Pt 1): 68-72
48. Fitzgerald GJ. Chemical warfare and medical response during World War I. American Journal of Public Health. 2008;98(4): 611-25
49. Le HQ, Knudsen SJ. Exposure to a First World War blistering agent, Emergency Medicine Journal. 2006;23: 296–99.
50. Medical management guidelines for blister agents: sulfur mustard agent H/HD, sulfur mustard agent HT. US Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry Web site. http://www.atsdr.cdc.gov/MMG/MMG.asp?id=924&tid=191. Accessed Dec 2018.
51. Medical management guidelines for blister agents: HN-1HN-2HN-3 nitrogen mustards. US Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry Web site. http://www.atsdr.cdc.gov/mmg/mmg.asp?id=920&tid=189. Accessed Dec 2018.
52. Johns Hopkins Center for Health Security, Sulfur mustard (blister agent) Fact Sheet, 25 Mar 2013. http://www.centerforhealthsecurity.org/resources/fact-sheets/pdfs/sulfur-mustard.pdf. Accessed Jan 2019
53. Wigenstam E, Jonasson S, Koch B, Bucht A. Corticosteroids treatment inhibits airway hyperresponsiveness and lung injury in a murine model of chemical-induced airway inflammation. Toxicology. 2012;301(103):66-71.
54. Vojvodić V, Milosavljević Z, Bosković B, Bojanić N. The protective effect of different drugs in rats poisoned by sulfur and nitrogen mustards. Fundamental and Applied Toxicology. 1985;5(6 Pt 2): S160-8.
55. Anderson DR, Byers SL, Vesely KR. Treatment of sulfur mustard (HD)-induced lung injury. Journal of Applied Toxicology. 2000;20(supp 1): S129-32.
56. Anderson DR, Holmes WW, Lee RB, et al. Sulfur mustard-induced neutropenia: treatment with granulocyte colony-stimulating factor. Military Medicine. 2006;171: 448-53.
57. Vijayaraghavan R, Kumar P, Joshi U, et al. Prophylactic wfficacy of amifostine and its analogues against sulfur musturd toxicity. Toxicology. 2001;163(2-3):83-91.
58. Bhattacharya IR, Rao PVL, Pant SC, et al. Effects of Amifostine and Its Analogues on Sulfur Mustard Toxicity in Vitro and in Vivo. Toxicology and Applied Pharmacology. 2001;176(1): 24-33.
59. Vilensky JA, Redman K. British anti-Lewisite (dimercaprol): an amazing history. Annals of Emergency Medicine. 2003;41(3): 378-83.
60. Medical management guidelines for blister agents: lewisite (L), mustard-lewisite mixture (HL). US Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry Web site. http://www.atsdr.cdc.gov/mmg/mmg.asp?id=922&tid=190. Accessed Dec 2018.
61. Ketchum JS, Sidell, FR. Incapacitating Agents. In: Borden Institute. Textbook of Military Medicine: Medical Aspects of Chemical Warfare. United States Department of Defense. 2009. https://ke.army.mil/bordeninstitute/published_volumes/chemwarfare/ch12_pgs411-440.pdf. Accessed Jan 2019.
62. Burns MJ, Linden CH, Graduins A, et al. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Annals of Emergency Medicine. 2000;35(4):374-381.
63. Wetherall J, Hall T, Passingham S. Physostigmine and hyoscamine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea pig. Neurotoxicology. 2002;23:341-349.
64. Boyer E. Management of opioid analgesic overdose. The New England Journal of Medicine. 2012;367(2): 146-55.
65. Schep LJ, Slaughter RJ, McBride DI. Riot control agents: the tear gases CN, CS and OC-a medical review. Journal of the Royal Army Medical Corps. 2015;161(2): 94-9.